Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-21-064924

COO & Chief Financial Officer acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LOWE CHRISTOPHER P. · COO & Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-11-16 Exercise or conversion : show line 1 in the form +30,000 $2.23 $66,900 90,000 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-11-16 Exercise or conversion : show line 2 in the form Stock Option (right to buy) −30,000 103,294 D
Loading xslF345X03/doc4.xml…